MC Plus Material – 03_Overview of the FY2026 Medical Fee Revision – 3. Acute and Highly Acute Inpatient Care – Page 8 – Center for Health Policy Information

Key News Points

Key points from materials (Center for Health Policy Information) regarding acute and highly acute inpatient care within the overview of the FY2026 medical fee revision. The importance of mid-to-long-term management and business succession strategies considering the revision cycle, the economies of scale through group participation (maintaining facility standards, distributing equipment investment burdens), and utilizing tax incentives by transitioning to specific or social medical corporations are raised as discussion points.

M&A Medical Editorial Department’s Perspective

This material, focusing on the overview of the FY2026 medical fee revision, particularly for acute and highly acute inpatient care, offers more than just a confirmation of the revision details. The necessity of mid-to-long-term management and succession strategies, looking ahead to the revision cycle, is a challenge faced by many medical institutions. Participation in a group, which allows for economies of scale, maintenance of facility standards, and distribution of equipment investment burdens, can be a realistic step to overcome investments and maintenance costs that are difficult to manage alone. Furthermore, transitioning to a specific medical corporation or a social medical corporation, in conjunction with utilizing tax schemes, is essential for early consideration to facilitate smooth asset transfer and continuity during business succession. These factors will likely serve as material for more concretely positioning M&A as an option when formulating individual medical institutions’ survival and development strategies.

Discussion Points Indicated by This News

• Analysis of the impact of revision details in acute and highly acute care on future revenue structures is urgently needed.
• Enjoying economies of scale through group formation is becoming a realistic option for maintaining facility standards and reducing equipment investment burdens.
• Transitioning to a specific or social medical corporation is key to a business succession scheme that maximizes tax benefits.
• The need to specifically simulate the linkage between mid-to-long-term management/succession strategies and medical fee revisions.

Practical Questions Arising from This News

• With the functional differentiation and strengthening of acute care beds progressing, can our hospital’s current functions be maintained after the revision?
• If we form a group, to what extent will management autonomy be lost? Also, what will be the treatment of existing physicians and staff?
• What are the specific benefits of tax incentives through becoming a social medical corporation? Also, what are the procedures associated with changing corporate status?

If You Feel “Should I Consult Too?”

Have you specifically calculated how the revision details focused on acute and highly acute care will affect your institution’s profitability and management sustainability? Also, considering the maintenance of facility standards and future equipment investment burdens, is continuing as a standalone entity the best option, or should alternatives such as group formation or changing corporate status be considered? An objective perspective may be necessary for consideration.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultations are available here.